← Back to all trials
Recruiting
NCT05641870
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
Conditions: Lung Cancer, Stage III Lung Cancer, Unresectable Lung Carcinoma
Sex: All
Ages: 18 Years – N/A
Enrollment: 80
Sponsor: Parc de Salut Mar
Location: Spain
Summary
Multi-center observational clinical study to evaluate the application value of ctDNA monitoring in efficacy assessment and relapse prediction in patients diagnosed with unresectable, locally advanced NSCLC receiving CRT with or without durvalumab maintenance treatment.
Eligibility Criteria
Inclusion Criteria:Patients with newly diagnosed, histologically confirmed, unresectable locally advanced NSCLC.≥18 years of age.Ability to understand the written informed consent and willingness to sign it.Exclusion Criteria:Patients who are unwilling to follow-up evaluation of response to therapy.Any condition that, in the opinion of the investigator, would interfere with study results.
Source: ClinicalTrials.gov (NCT05641870). StuddyBuddy aggregates publicly available trial information.
